Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
2-[4-(2H-1,4-benzothiazine-3-yl)-piperazine-1-yl]-1,3-thiazole-4-carboxylic acid ethylester
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule belonging to the n‐arylpiperazines class. It features a benzothiazine motif linked via piperazine to a thiazole carboxylic acid ethyl ester. The structure incorporates several heterocycles (benzothiazine, piperazine, thiazole), which are common in medicinal chemistry for their potential bioactivity. While it has been explored as an experimental agent and is catalogued in drug discovery databases (e.g., DrugBank DB08540), there are no approved indications or clinical trials reported for this molecule. Its mechanism of action and biological targets remain uncharacterized in public sources; however, the presence of these motifs suggests possible activity on central nervous system pathways or other receptor systems relevant to neuropharmacology or related fields[1][6].
- Other names
- ethyl 2-[4-(2H-1,4-benzothiazin-3-yl)piperazin-1-yl]-1,3-thiazole-4-carboxylate2-[4-(2H‑1,4‑benzothiazine‑3‑yl)‑piperazine‑1‑ly]‑1,3‑thiazole‑4–carboxylic acid ethylether
Beyond the preview
Go deeper on 2-[4-(2H-1,4-benzothiazine-3-yl)-piperazine-1-yl]-1,3-thiazole-4-carboxylic acid ethylester.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 2-[4-(2H-1,4-benzothiazine-3-yl)-piperazine-1-yl]-1,3-thiazole-4-carboxylic acid ethylester.